Neuromuscular deterioration in the early stage of sepsis in rats
© Cankayali et al.; licensee BioMed Central Ltd. 2006
Received: 20 January 2006
Accepted: 4 January 2007
Published: 4 January 2007
Critical illness polyneuropathy (CIP) is a clinical condition frequently seen in patients being treated in critical care units in the final stage of sepsis. The etiopathology of CIP is still unclear, and the onset time of appearance of the electrophysiological findings has not been elucidated. The very little research that has been carried out on this topic is limited to clinical electrophysiological and histopathological studies. In this study, electrophysiological alterations in the early stage of experimentally induced sepsis were investigated in septic rats.
We conducted a prospective, randomized, controlled experimental study in an animal basic science laboratory with 30 male Sprague-Dawley rats, weighing 200 to 250 g. All of the rats were randomly assigned to one of two groups. In the sepsis group (n = 20), cecal ligation and puncture (CLP) was performed to induce experimental sepsis. In the sham-operated group (n = 10), laparotomy without CLP was performed. Before and 24 hours after CLP and laparotomy, the right sciatic nerve was stimulated from the sciatic notch and compound muscle action potentials (CMAPs) were recorded from the gastrocnemius muscle. Recordings of latency, amplitude, and duration of the CMAP were evaluated.
CMAP durations before and 24 hours after surgery were 0.45 ± 0.05 ms and 0.48 ± 0.05 ms, respectively, in the sham-operated group and 0.46 ± 0.05 ms and 0.55 ± 0.01 ms, respectively, in the sepsis group. Latency measurements in the sham-operated group were 0.078 ± 0.010 ms and 0.080 ± 0.015 ms, respectively, whereas measurements were found to be prolonged in the sepsis group: 0.094 ± 0.015 ms and 0.149 ± 0.054 ms before and 24 hours after surgery, respectively (p < 0.05). CMAP amplitudes in the sham-operated group before and 24 hours after surgery were 8.41 ± 0.79 mV and 8.28 ± 1.92 mV, respectively, whereas in the sepsis group the amplitude measurements decreased to 7.60 ± 1.75 mV and 4.87 ± 3.44 mV, respectively (p < 0.05).
The results of the study indicate that electrophysiological alterations appear in the first 24 hours after experimental sepsis and are characterized by an increase in latency and a decrease in CMAP amplitude. The results also suggest that electrophysiological findings seen in patients with CIP might appear before clinical signs of CIP.
Critical illness polyneuropathy (CIP) was described as a clinical disorder by Bolton and colleagues  in 1984. It is a primary axonal degeneration of motor and sensory fibers which occurs mostly in patients who have systemic inflammatory response syndrome (SIRS), sepsis, or multiple organ dysfunction syndrome (MODS) [2–7]. Berek and colleagues  suggested that, in the course of sepsis, CIP has to be considered part of MODS.
CIP manifests with general weakness and sensory defects and especially with weakness of the respiratory muscles, leading to problems in weaning from mechanical ventilation in the intensive care unit (ICU). Physiopathology, onset of the symptoms, and the treatment of CIP have not been clearly defined.
The studies on CIP are based mostly on clinical manifestations and neurophysiological research. However, an experimental study investigating possible neuromuscular changes in the early stage of sepsis has not been performed yet. We aimed to observe electrophysiological alterations in the early stage of sepsis. In this study, an experimental sepsis model was performed to investigate electrophysiological alterations in the first 24 hours of sepsis.
Materials and methods
Animal Ethics Committee approval was obtained, and the study was conducted in the Research Laboratory of the Department of Anesthesiology and ICU of Ege University Medical School (Izmir, Turkey).
Thirty adult male Sprague-Dawley rats two to three months old, each weighing approximately 250 g, were used. All rats were housed in cages one week before the experiments in an acclimatized room at standard room temperature and with twelve hour light/dark cycles. Rats were allowed free access to water and standard chow. For surgical intervention, rats were anesthetized with ketamine (80 mg/kg) and xylazine (10 mg/kg) given intraperitoneally.
All rats were randomly divided into one of two groups: a cecal ligation and puncture (CLP)-operated group (sepsis group) (n = 20) and a sham-operated group (sham group) (n = 10). Due to the sepsis model's high mortality rate, more rats were grouped in the sepsis group (n = 20) than in the sham group (n = 10). For reliable statistical results, at least six rats is sufficient. We decided to perform the study with at least 10 rats.
Sepsis was induced by CLP performed as described previously [9, 10]. In this sepsis model, five hours after CLP, rats were accepted as septic. Under aseptic conditions, a 3-cm midline laparotomy was performed to allow exposure of the cecum with adjoining intestine. The cecum was ligated tightly with a 3.0 silk suture at its base below the iliocecal valve and perforated once with a 22-gauge needle. The cecum was then gently squeezed to extrude a small amount of feces from the perforation site. The cecum was returned to the peritoneal cavity, and the laparotomy incision was closed with 4.0 silk sutures. In the sham group, under aseptic conditions only, laparotomy was performed on rats, but their cecum was neither ligated nor punctured.
Measurements and calculations
Because we aimed to assess EMG recordings in the early stage of sepsis, we obtained EMG recordings of the rats in the first 24 hours after CLP. We did not aim to observe clinical signs of sepsis; therefore, the animals were euthanized 24 hours after surgery.
The results were analyzed with the SPSS ver 14.0 statistical program (SPSS Inc., 233 South wacker Drive, 11th floor, Chicago, IL 60606-6307) by using repeated measures (analysis of variance). Factors were session (before and 24 hours after surgery) and treatment (sepsis and sham groups). Dependent variables were latency, amplitude, and duration. The groups were compared by paired-sample t test, and results were given as mean ± standard deviation. A value of p > 0.05 was accepted as statistically significant.
In the sepsis group, five rats died during the first 24 hours and were excluded from the study. At 24 hours, the mortality rate was 25% in the sepsis group, and there was no mortality in the sham group. The mortality rate was high in the sepsis group because we did not use treatment materials (antibiotics and fluid resuscitation) for this study.
Measurements of compound gastrocnemius muscle action potentials
CMAP duration (ms)
CMAP amplitude (mV)
24 hours after surgery
24 hours after surgery
24 hours after surgery
0.46 ± 0.05
0.55 ± 0.01
7.60 ± 1.75
4.87 ± 3.44a
0.094 ± 0.015
0.149 ± 0.054a
0.45 ± 0.005
0.48 ± 0.05
8.41 ± 0.79
8.28 ± 1.92
0.078 ± 0.010
0.080 ± 0.015
Latency measurements were not significantly altered in the sham group (from 0.078 ± 0.010 ms to 0.080 ± 0.015 ms), whereas measurements were found to be prolonged in the sepsis group (from 0.094 ± 0.015 ms to 0.149 ± 0.054 ms) before and 24 hours after surgery, respectively (p < 0.05). Latency data showed significant difference only in the sepsis group, and interacted for session (F1,23 = 13.47, p = 0.001) and treatment (F1,23 = 15.86, p = 0.001) (F1,23 = 11.98, p = 0.002). Whereas latency time was prolonged in the sepsis group in a significant manner (ratio of the prolonged amount = 56.45%), latency time was prolonged much less in the sham group (ratio of the prolonged amount = 2.4%) (Table 1).
CMAP duration and latency increase and CMAP amplitude decrease in the sham group was not statistically significant (p > 0.05).
CIP is a neuromuscular pathology regarded as a neurological complication of sepsis given that CIP may have always accompanied sepsis [3–6, 8, 11, 12]. Underlying primary illness or the type of trauma, metabolic disorders, hypoxia, nutritional deficiencies, and medications such as antibiotics, neuromuscular blocking agents, and corticosteroids are insufficient to reveal the potential causes of CIP [2, 4]. However, etiology, pathogenesis, time of onset, preventive measures, and therapy of CIP are still controversial and could not be defined clearly. In patients with sepsis and SIRS, the seriousness of the underlying disease and treatments with neuromuscular drugs and opioids and mechanical ventilation may conceal the onset and symptoms of CIP and may delay the diagnosis of CIP. Therefore, electrophysiological examination is the most important tool in the early diagnosis and course of CIP [2, 13]. But the muscle fibrillation potentials and positive sharp waves cannot be observed before three weeks of sepsis. Otherwise, the latency changes that are accepted as typical for axonal damage and the decrease of the motor action potential (CMAP) amplitude may appear in the first week of sepsis. They are regarded as the earliest electrophysiological signs of CIP. Despite denervation, signs have been found on the fifth day; in some studies, spontaneous EMG activity cannot be expected before the 10th or 14th day of acute denervation . In the electrophysiological research of Tennila and colleagues , CMAP amplitudes of median and ulnar nerves were found to be decreased on the fifth day in nine mechanically ventilated patients with SIRS and/or MODS. In addition, abnormal spontaneous activities such as sharp positive waves and fibrillation potentials were found to be present in EMG recordings in their clinical series.
In this study, CMAP amplitude was decreased; regarding the first electrophysiological finding in the early phase of CIP [2, 6, 16] and marked prolongation of latency values appeared in the first 24 hours of sepsis. Our findings are supported by the previous studies. In some earlier studies, it was postulated that decrease in the CMAP amplitude was due primarily to neuromuscular blocking agents, steroids, and some medications used widely in ICUs [4, 17–19]. However, the latest prospective studies have shown that there is no correlation with CIP, critical illness myopathy, and medication used [5, 6, 20]. In the present study, the neurophysiological conduction alterations were seen in the experimental CIP model without using neuromuscular blocking agents and/or steroids. Therefore, these findings support the concept that sepsis is mainly responsible for the neuromuscular changes. Likewise, antibiotics, especially aminoglycosides and their metabolites, are said to be the other factors responsible for development of CIP that results from the increase of capillary membrane permeability and the invasion of antibiotics to peripheral nerves in sepsis . However, there is no statistical evidence confirming these opinions, and thus further studies are needed. Given that antibiotics were not used in our experimental sepsis model, our results support the idea that the observed electrophysiological alterations were attributable entirely to sepsis.
Disturbances in microcirculation and autoregulation of peripheral nerves, as well as the other organs influenced in sepsis, are thought to be the principal causes of the development of CIP. In addition, cytokines released in sepsis also cause an increase in capillary permeability due to a histamine-like effect and the resulting endoneural edema leads to hypoxia and energy deficit by increasing the intercapillary space . Because the axonal transportation of structural proteins is highly energy-dependent, this energy deficit induces primary axonal degeneration of distal nerves . Bolton and colleagues  suggested that tumor necrosis factor, arachidonic acid, and metabolites of histamine, complement activation, cellular adhesion systems, and free radicals were principal factors responsible for systemic effects of sepsis and SIRS and these factors might lead to primary axonal degeneration.
Electrophysiological measurements in the early studies obtained during early periods of clinical sepsis indicated that the decrease in amplitude of CMAP was accompanied by an increase in duration without any change in latency. This finding directed attention to the muscle fiber membrane as a physiopathological explanation . Decrease in CMAP amplitude and increase in duration were suggested to be secondary to the dysfunction of energy-dependent sodium-potassium pumps in muscles . In the present study, although there was an increase in the duration 24 hours after sepsis was induced, the difference was not statistically significant when compared with the sham group. Our results do not show the prolongation of duration which has been shown in the previous studies, due to electrophysiological data that were obtained in the early stages (24 hours) of sepsis in this study. The prolongation of the duration due to sodium-potassium pump insufficiency in the muscles has been accepted as an indicator observed in the later stages of sepsis. Our results indicate no change in CMAP duration but a decrease in amplitude and observable prolongation of the latency which is regarded as an indicator of axonal degeneration. Further detailed studies should be designed to elucidate the pathogenesis properly. The common point in the majority of the related articles is the presence of a decrease of CMAP amplitude. CMAP is produced by synchronized activation of the muscle fibers after axonal innervations, which is the sum of the responses of the striated muscles to stimuli. In addition, CMAP is a valuable tool both for evaluating to descending motor axon and the response of the muscle fibers to the stimulus placed distally and the conduction at the neuromuscular junction . In this study, CMAP changes indicate possible axonal conduction and/or neuromuscular junction pathologies or a reduced number of fibers responding to stimulus. But we were not able to distinguish and define the origin of the observed changes such as axonal conduction defects, neuromuscular junction pathologies, or reduction of the number of the muscle fibers that led to the decrease of the amplitude and prolongation of CMAP in the sepsis group.
Our results indicate that electrophysiological findings appeared in the first 24 hours after experimental sepsis and were characterized by an increase in latency and a decrease in CMAP amplitude. Therefore, we conclude that electrophysiological changes seen in sepsis might appear before clinical signs of CIP.
CMAP durations were increased in a sepsis model in rats in the first 24 hours.
CMAP amplitudes were significantly decreased in a sepsis model in rats in the first 24 hours.
Latency times were significantly prolonged in a sepsis model in rats in the first 24 hours.
Electrophysiological changes seen in sepsis might appear before clinical signs of CIP.
critical illness polyneuropathy
cecal ligation and puncture
compound muscle action potential
intensive care unit
multiple organ dysfunction syndrome
systemic inflammatory response syndrome.
- Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984, 47: 1223-1231.PubMed CentralView ArticlePubMedGoogle Scholar
- Zochodne DW, Bolton CF, Wells GA: Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987, 110: 819-841. 10.1093/brain/110.4.819View ArticlePubMedGoogle Scholar
- Bolton CF: Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996, 24: 1408-1416. 10.1097/00003246-199608000-00022View ArticlePubMedGoogle Scholar
- Witt NJ, Zochodne DW, Bolton CF: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99: 176-184.View ArticlePubMedGoogle Scholar
- Leijten FS, de Weerd AW: Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994, 96: 10-19. 10.1016/0303-8467(94)90023-XView ArticlePubMedGoogle Scholar
- Zifko UA, Zipko HT, Bolton CF: Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998, 159: 186-193. 10.1016/S0022-510X(98)00164-6View ArticlePubMedGoogle Scholar
- Motomura M: [Critical illness polyneuropathy and myopathy.] (Abstract). Rinsho Shinkeigaku 2003, 43: 802-804.PubMedGoogle Scholar
- Berek K, Margreiter J, Willeit J: [Polyneuropathy in the critically ill patient – critical illness polyneuropathy.] (Abstract). Wien Klin Wochenschr 1998, 110: 243-252.PubMedGoogle Scholar
- Otero-Anton E, Gonzalez-Quintela A, Lopez-Soto A, Lopez-Ben S, Llovo J, Perez LF: Cecal ligation and puncture as a model of sepsis in the rat: influence of the puncture size on mortality, bacteremia, endotoxemia and tumor necrosis factor alpha levels. Eur Surg Res 2001, 33: 77-79. 10.1159/000049698View ArticlePubMedGoogle Scholar
- Ritter C, Andrades M, Frota Junior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, Dal-Pizzol F: Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 2003, 29: 1782-1789. 10.1007/s00134-003-1789-9View ArticlePubMedGoogle Scholar
- Lorin S, Nierman DM: Critical illness neuromuscular abnormalities. Crit Care Clin 2002, 18: 553-568. 10.1016/S0749-0704(02)00003-9View ArticlePubMedGoogle Scholar
- van Mook WN, Hulsewe-Evers RP: Critical illness polyneuropathy. Curr Opin Crit Care 2002, 8: 302-310. 10.1097/00075198-200208000-00006View ArticlePubMedGoogle Scholar
- Druschky A, Herkert M, Radespiel-Troger M, Druschky K, Hund E, Becker CM, Hilz MJ, Erbguth F, Neundorfer B: Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001, 27: 686-693. 10.1007/s001340100890View ArticlePubMedGoogle Scholar
- Bolton CF, Young GB, Zochodne DW: The neurological complications of sepsis. Ann Neurol 1993, 33: 94-100. 10.1002/ana.410330115View ArticlePubMedGoogle Scholar
- Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O: Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000,26(9):1360-1363. 10.1007/s001340000586View ArticlePubMedGoogle Scholar
- Schwarz J, Planck J, Briegel J, Straube A: Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997, 20: 696-701. 10.1002/(SICI)1097-4598(199706)20:6<696::AID-MUS6>3.0.CO;2-3View ArticlePubMedGoogle Scholar
- Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ: Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996, 40: 645-654. 10.1002/ana.410400415View ArticlePubMedGoogle Scholar
- Wernig A, Pecot-Dechavassine M, Stover H: Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare. J Neurocytol 1980, 9: 278-303. 10.1007/BF01181538View ArticlePubMedGoogle Scholar
- Coakley JH, Nagendran K, Ormerod IE, Ferguson CN, Hinds CJ: Prolonged neurogenic weakness in patients requiring mechanical ventilation for acute airflow limitation. Chest 1992, 101: 1413-1416.View ArticlePubMedGoogle Scholar
- Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ: Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996, 22: 849-855.View ArticlePubMedGoogle Scholar
- Spitzer AR, Giancarlo T, Maher L, Awerbuch G, Bowles A: Neuromuscular causes of prolonged ventilator dependency. (Abstract). Muscle Nerve 1992,15(6):682-686. 10.1002/mus.880150609View ArticlePubMedGoogle Scholar
- Bolton CF: Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med 2000, 26: 1179-1180. 10.1007/s001340000622View ArticlePubMedGoogle Scholar
- Milner-Brown HS, Miller RG: Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve 1986, 9: 367-374. 10.1002/mus.880090415View ArticlePubMedGoogle Scholar
- Daube JR: Compound muscle action potentials. In Clinical Neurophysiology. Edited by: Daube JR. Philadelphia: F A Davis Company; 1996:199-234.Google Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.